Search clinical trials for: Direct boost mRNA

Total 6991 results

Seattle Children's Hospital
University of Washington; Ohio State University; Nationwide Children's Hospital; Children's Hospital Los Angeles

Enrolling by invitation

Book Sharing for Toddlers With Clefts (BOOST)

Cleft Lip and Palate | Cleft Palate

United States
University Health Network, Toronto

Active, not recruiting

A Feasibility Study Evaluating Surgery for Mesothelioma After Radiation Therapy Using Extensive Pleural Resection (SMARTER)

Mesothelioma; Lung

Canada
UMC Utrecht

Completed

FLAME: Investigate the Benefit of a Focal Lesion Ablative Microboost in Prostate Cancer (FLAME)

MRI | Prostate Cancer | Radiotherapy

Belgium, Netherlands
Jill Hamilton-Reeves, PhD RD LD
American Cancer Society, Inc.; Société des Produits Nestlé (SPN)

Completed

Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study

Urinary Bladder Neoplasms | Surgery | Bladder Cancer | Radical Cystectomy

United States
ModernaTX, Inc.

Recruiting

A Study to Investigate the Immunogenicity and Safety of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in High-risk Adults

Respiratory Syncytial Virus

Canada, United States, United Kingdom, Puerto Rico
Rigshospitalet, Denmark
Innovation Fund Denmark; Ministry of Education, Denmark

Recruiting

Myopericarditis After Messenger Ribonucleic Acid (mRNA) COVID-19 Vaccination in Children 5-11 Years Old

Myocarditis | SARS-CoV2 Infection | Myopericarditis | Vaccination; Complications | COVID-19 Pandemic

Denmark
ModernaTX, Inc.

Completed

A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants

SARS-CoV-2

United States
University Hospital, Lille

Completed

Preventive Effect of Proprioceptive Stimulation on Muscle Atrophy (PrevAtrophy)

Knee Arthritis

France
Seqirus

Active, not recruiting

Safety, Reactogenicity, and Immunogenicity Study of a Self-Amplifying mRNA Influenza Vaccine in Healthy Adults

Influenza, Human

Australia
Israel Institute for Biological Research (IIBR)

Completed

Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine

Covid19

Israel
National Institute of Allergy and Infectious Diseases...

Completed

Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines

COVID-19

United States
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients (UNIQUE)

Breast Cancer | Radiotherapy Side Effect

China
Maria Sklodowska-Curie National Research Institute...

Recruiting

Radiotherapy With Hyperthermia in Recurrent and Radiation-Induced Sarcomas (HOT)

Recurrent Soft Tissue Sarcoma | Recurrent Sarcoma | Radiation Induced Neoplasms | Radiation-Induced Cancer

Poland
Fundación de Investigación Biomédica - Hospital...

Active, not recruiting

VMAT for Dominant Intraprostatic Lesion (CaP-VMAT-DIL)

Prostate Cancer

Spain
Sunnybrook Health Sciences Centre

Active, not recruiting

MRI Assisted Focal Boost With HDR Monotherapy for Prostate Cancer Patients (MARS)

Prostate Cancer

Canada
Christian Medical College, Vellore, India
Karolinska Institutet; Vinnova; Ministry of Science and Technology, India

Unknown

Boost to Brittle Bones - Stem Cell Transplantation for Treatment of Brittle Bones (BOOST2B)

Osteogenesis Imperfecta

India
Fondazione Policlinico Universitario Agostino Gemelli...

Unknown

Reduction of Pain Symptoms With Stereotactic Radiotherapy on Bone Metastases (PREST)

Bone Metastases | Radiotherapy | Technology
University Hospital, Ghent

Completed

Comparison of Acute Toxicity and Cost Between Whole Breast Irradiation With Sequential Boost and Simultaneous Integrated Boost After Breast Conserving Surgery. (SeqB vs SIB)

Radiotherapy After Breast Conserving Surgery

Belgium
Chang Gung Memorial Hospital

Recruiting

Immunogenicity of COVID-19 Vaccine on Heterologous Schedule

Healthy | Covid-19 | Vaccine | Immunogenicity | Reactogenicity

Taiwan
Medifast, Inc.
BioFortis

Completed

Weight Loss Using the Take Shape For Life Program or the Medifast Direct Program Versus a Self-Directed Diet

Obesity | Overweight

United States
Nova Scotia Health Authority
Obafemi Awolowo University

Not yet recruiting

Molecular Subtyping of Triple-negative Breast Cancer and African Ancestry-related Immunogenicity

Triple Negative Breast Cancer
Tang-Du Hospital
Air Force Military Medical University, China

Not yet recruiting

Exosome-based Nanoplatform for Ldlr mRNA Delivery in FH (ENDFH)

Familial Hypercholesterolemia

China
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France

Not yet recruiting

Immunogenecity and Safety of VaccinemRNA-1273 in Elderly Volunteers (Over 65 y) Compared to Younger Ones (18-45y) (CoviCompareM)

Prevention of COVID19
ModernaTX, Inc.

Active, not recruiting

A Study of the Effectiveness of Moderna COVID-19 Vaccine

COVID-19 | SARS-CoV-2

United States
Maria Joyera Rodríguez

Withdrawn

Study About the Response to the Administration of a Third Dose of mRNA-1273 Vaccine (COVID-19 Vaccine Moderna) in Renal Transplants With Immunological Failure Initial to Vaccination (VAX-TRES)

Covid19
Shandong Cancer Hospital and Institute

Recruiting

Shandong Cancer Hospital Affiliated to Shandong University

Early-stage Breast Cancer | Breast Conserving Surgery

China
Société des Produits Nestlé (SPN)
Ecole Polytechnique Fédérale de Lausanne

Completed

Phosphate Metabolites in Brain of Humans Aged 50+

Basic Science

Switzerland
Fudan University

Unknown

Hypofractionated Whole-breast Irradiation With Simultaneously Integrated Boost For Early-Stage Breast Cancer After Breast-conserving Surgery (HF-WBI-SIB)

Breast Cancer

China
European Institute of Oncology
Associazione Italiana per la Ricerca sul Cancro

Recruiting

Carbon Ions Boost Followed by Pelvic Photon Radiotherapy for High Risk Prostate Cancer

Adenocarcinoma of Prostate

Italy
Centre Henri Becquerel
Intergroupe Francophone de Cancerologie Thoracique

Unknown

Study of Interest of Personalized Radiotherapy Dose Redistribution in Patients With Stage III NSCLC (RTEP7)

Non-small Cell Lung Cancer

France
Second Affiliated Hospital of Guangzhou Medical...

Not yet recruiting

Anti-cancer Neoantigen mRNA Vaccine to Treat Solid Tumors

Solid Tumor, Adult
ModernaTX, Inc.

Recruiting

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.

Cytomegalovirus Infection

United States
ModernaTX, Inc.

Active, not recruiting

A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age

Respiratory Syncytial Virus

United States, Spain, Taiwan, Korea, Republic of, Singapore, Canada, Belgium, Finland, Japan, United Kingdom, Chile, New Zealand, South Africa, Australia, Puerto Rico, Argentina, Costa Rica, Poland, Bangladesh, Colombia, Germany, ... and more
ModernaTX, Inc.

Active, not recruiting

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

Cytomegalovirus Infection

United States, Australia, Canada, France, Belgium, Germany, Israel, Italy, United Kingdom, Spain, Estonia, Finland, Japan
ModernaTX, Inc.
National Institute of Allergy and Infectious Diseases (NIAID); Biomedical Advanced...

Completed

A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19

SARS-CoV-2

United States
ModernaTX, Inc.

Active, not recruiting

A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus

Respiratory Syncytial Virus

United States, Panama
Trakya University

Unknown

Gene Expression and DNA Variation Analysis of Sacs to Identify the Pathophysiology of Indirect Inguinal Hernia

Genetic Predisposition to Disease | Indirect Inguinal Hernia

Turkey
ModernaTX, Inc.

Completed

Safety, Reactogenicity, and Immunogenicity of mRNA-1653 in Healthy Adults

Human Metapneumovirus and Human Parainfluenza Infection

United States
University of Florida

Withdrawn

Human Telomerase Reverse Transcriptase Messenger RNA (hTERT mRNA) Transfected Dendritic Cell Vaccines

Metastatic Prostate Cancer
IrsiCaixa
Hospital Clinic of Barcelona; University of Oxford; Fundación FLS de Lucha Contra... and other collaborators

Completed

Safety and Immunogenicity of ChAdV63.HIVconsv and MVA.HIVconsv Candidate HIV-1 Vaccines in Recently HIV-1 Infected Individuals

HIV

Spain
Karolinska University Hospital
Karolinska Institutet

Active, not recruiting

COVID-19 Vaccination of Immunodeficient Persons (COVAXID) (COVAXID)

Covid19

Sweden
University of Michigan

Terminated

Routine Post-Operative Supplemental Nutrition

Esophageal Cancer

United States
University of Aarhus
Odense University Hospital; Rigshospitalet, Denmark; Herlev Hospital; Vejle Hospital and other collaborators

Completed

DAPROCA Pelvic Lymph Node Irradiation to Prostate for High Risk Prostate Cancer: Phase I/II Study (Propel)

Prostate Cancer

Denmark
National Institute of Allergy and Infectious Diseases...
Moderna TX, Inc

Active, not recruiting

Dose Escalation, Open-Label Clinical Trial to Evaluate Safety, Tolerability and Immunogenicity of a Nipah Virus (NiV) mRNA Vaccine, mRNA-1215, in Healthy Adults

Nipah Virus Infection

United States
National Institute of Allergy and Infectious Diseases...
ModernaTX, Inc.

Completed

Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)

COVID-19 | COVID-19 Immunisation

United States
ModernaTX, Inc.

Enrolling by invitation

A Long-Term Extension Study to Evaluate the Immunogenicity and Safety of Cytomegalovirus (CMV) mRNA-1647 Vaccine

Cytomegalovirus Infection

United States
H. Lee Moffitt Cancer Center and Research Institute
ModernaTX, Inc.

Completed

COVID-19 Immunogenicity of a Third Dose of mRNA-1273 Vaccine Among Cancer Patients

Covid19 | SARS-CoV2 Infection

United States
Radboud University Medical Center
Rotterdam Eye Hospital

Terminated

Messenger Ribonucleic Acid (mRNA) Transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients

Uveal Melanoma

Netherlands
Maastricht University Medical Center

Terminated

BOOSTH: Serious Gaming in Combination With Physical Activity Promotion

Physical Activity | Childhood Obesity | Overweight and Obesity | Serious Game

Netherlands
Universiteit Antwerpen

Completed

Immunogenicity After COVID-19 Vaccines in Adapted Schedules (IMCOVAS)

COVID-19 | Coronavirus Disease 2019

Belgium

Search clinical trials for: Direct boost mRNA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations